应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WGS GeneDx Holdings
休市中 09-19 16:00:00 EDT
129.61
-1.10
-0.85%
盘后
129.61
+0.00
0.00%
19:29 EDT
最高
132.01
最低
127.32
成交量
54.54万
今开
130.53
昨收
130.71
日振幅
3.59%
总市值
37.23亿
流通市值
25.85亿
总股本
2,873万
成交额
7,049万
换手率
2.73%
流通股本
1,994万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Genedx Holdings Corp.盘中异动 下午盘大幅上涨5.06%
市场透视 · 08-12
Genedx Holdings Corp.盘中异动 下午盘大幅上涨5.06%
Genedx Holdings Corp.盘中异动 大幅上涨5.11%
市场透视 · 08-05
Genedx Holdings Corp.盘中异动 大幅上涨5.11%
Genedx Holdings Corp.2025财年第二财季实现净利润10.81百万美元,同比增加137.06%
市场透视 · 08-03
Genedx Holdings Corp.2025财年第二财季实现净利润10.81百万美元,同比增加137.06%
Genedx Holdings Corp.跌3.73% 股价跌破100美元大关
市场透视 · 07-31
Genedx Holdings Corp.跌3.73% 股价跌破100美元大关
异动解读 | GeneDx Holdings盘中大涨5.33%,Q2财报表现强劲
异动解读 · 07-30
异动解读 | GeneDx Holdings盘中大涨5.33%,Q2财报表现强劲
Genedx Holdings Corp.盘中异动 早盘股价大涨5.00%报96.37美元
市场透视 · 07-30
Genedx Holdings Corp.盘中异动 早盘股价大涨5.00%报96.37美元
美股财报 | GeneDx Holdings发布Q2财报 前半年累计净利润428.00万美元
同花顺iNews · 07-30
美股财报 | GeneDx Holdings发布Q2财报 前半年累计净利润428.00万美元
异动解读 | 业绩超预期,GeneDx Holdings夜盘大涨5.69%
异动解读 · 07-30
异动解读 | 业绩超预期,GeneDx Holdings夜盘大涨5.69%
异动解读 | 业绩超预期,GeneDx Holdings盘前大涨29.08%
异动解读 · 07-29
异动解读 | 业绩超预期,GeneDx Holdings盘前大涨29.08%
GUIDANCE: (WGS) GeneDx Expects Full Year 2025 Revenue Range $400M - $415M, vs. FactSet Est of $369.4M
MT Newswires Live · 07-29
GUIDANCE: (WGS) GeneDx Expects Full Year 2025 Revenue Range $400M - $415M, vs. FactSet Est of $369.4M
GeneDx Hldgs Q2 2025 Adj. EPS $0.50 May Not Be Comparable To $0.10 Estimate, Sales $102.692M Beat $85.773M Estimate
Benzinga · 07-29
GeneDx Hldgs Q2 2025 Adj. EPS $0.50 May Not Be Comparable To $0.10 Estimate, Sales $102.692M Beat $85.773M Estimate
Genedx Holdings Corp.盘中异动 股价大涨5.36%
市场透视 · 07-29
Genedx Holdings Corp.盘中异动 股价大涨5.36%
Genedx Holdings Corp.盘中异动 急速跳水5.06%报82.51美元
市场透视 · 07-12
Genedx Holdings Corp.盘中异动 急速跳水5.06%报82.51美元
Genedx Holdings Corp.盘中异动 下午盘股价大跌5.07%报87.22美元
市场透视 · 07-11
Genedx Holdings Corp.盘中异动 下午盘股价大跌5.07%报87.22美元
Genedx Holdings Corp.盘中异动 早盘大幅拉升5.22%报89.67美元
市场透视 · 07-09
Genedx Holdings Corp.盘中异动 早盘大幅拉升5.22%报89.67美元
Genedx Holdings Corp.盘中异动 早盘快速下跌5.03%
市场透视 · 07-07
Genedx Holdings Corp.盘中异动 早盘快速下跌5.03%
Genedx Holdings Corp.盘中异动 早盘股价大涨5.01%报95.45美元
市场透视 · 06-25
Genedx Holdings Corp.盘中异动 早盘股价大涨5.01%报95.45美元
Genedx Holdings Corp.盘中异动 快速下跌5.03%
市场透视 · 06-24
Genedx Holdings Corp.盘中异动 快速下跌5.03%
国家重大研发专项支持项目获重大突破
市场资讯 · 06-20
国家重大研发专项支持项目获重大突破
Genedx Holdings Corp.盘中异动 股价大跌5.04%报66.78美元
市场透视 · 06-12
Genedx Holdings Corp.盘中异动 股价大跌5.04%报66.78美元
加载更多
公司概况
公司名称:
GeneDx Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
GeneDx Holdings Corp.是一家于2020年7月10日在特拉华州注册成立的公司,Sema4是一家以患者为中心的健康情报公司,致力于通过数据驱动的洞察力推进医疗保健。Sema4通过将人工智能和机器学习应用于多维、纵向临床和基因组数据来构建人类健康的动态模型并定义最佳的个性化健康轨迹,从而改变医疗保健。Centrellis是他们创新的健康智能平台,能够更全面地了解疾病和健康,并为最紧迫的医疗需求提供科学驱动的解决方案。
发行价格:
--
{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":129.605,"timestamp":1758312000000,"preClose":130.71,"halted":0,"volume":545373,"hourTrading":{"tag":"盘后","latestPrice":129.605,"preClose":129.605,"latestTime":"19:29 EDT","volume":17126,"amount":2219562.523,"timestamp":1758324559591},"delay":0,"floatShares":19944938,"shares":28726248,"eps":0.048463,"marketStatus":"休市中","change":-1.105,"latestTime":"09-19 16:00:00 EDT","open":130.53,"high":132.01,"low":127.32,"amount":70492797.93276,"amplitude":0.035881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.048463,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758528000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":130.71,"preHourTrading":{"tag":"盘前","latestPrice":131.99,"preClose":130.71,"latestTime":"09:27 EDT","volume":265,"amount":34428.77085,"timestamp":1758288478143},"postHourTrading":{"tag":"盘后","latestPrice":129.605,"preClose":129.605,"latestTime":"19:29 EDT","volume":17126,"amount":2219562.523,"timestamp":1758324559591},"volumeRatio":1.1439847633515696,"impliedVol":0.6226,"impliedVolPercentile":0.084},"requestUrl":"/m/hq/s/WGS","defaultTab":"news","newsList":[{"id":"2558664031","title":"Genedx Holdings Corp.盘中异动 下午盘大幅上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664031?lang=zh_cn&edition=full","pubTime":"2025-08-12 01:08","pubTimestamp":1754932097,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日01时08分,Genedx Holdings Corp.股票出现波动,股价急速上涨5.06%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.25%。其相关个股中,Radnet, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global涨幅较大,Ispecimen Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃,换手率分别为8.76%、3.69%、2.95%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Radnet, Inc.、Prophase Labs, Inc.,振幅分别为24.55%、15.37%、13.84%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812010817a4825ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2557033347","title":"Genedx Holdings Corp.盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557033347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557033347?lang=zh_cn&edition=full","pubTime":"2025-08-05 00:46","pubTimestamp":1754325962,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日00时46分,Genedx Holdings Corp.股票出现异动,股价快速上涨5.11%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为3.47%。其相关个股中,爱德士、Genedx Holdings Corp C/Wts 22/07/2026 、燃石医学涨幅较大,Mainz Biomed N.V.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃,换手率分别为15.27%、9.68%、5.83%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Advanced Biomed Inc.、Mainz Biomed N.V.,振幅分别为32.08%、19.86%、15.41%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805004602a6d2c51d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2556042825","title":"Genedx Holdings Corp.2025财年第二财季实现净利润10.81百万美元,同比增加137.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556042825","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556042825?lang=zh_cn&edition=full","pubTime":"2025-08-03 00:01","pubTimestamp":1754150463,"startTime":"0","endTime":"0","summary":"8月3日,Genedx Holdings Corp.公布财报,公告显示公司2025财年第二财季净利润为10.81百万美元,同比增加137.06%;其中营业收入为1.03亿美元,同比增加46.08%,每股基本收益为0.38美元。从资产负债表来看,Genedx Holdings Corp.总负债1.87亿美元,其中短期债务4.31百万美元,资产负债比为2.49,流动比率为0.03。机构评级:截至2025年8月3日,当前有7家机构对Genedx Holdings Corp.目标价做出预测,其中目标均价为113.86美元,其中最低目标价为95.00美元,最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000113a4717660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS"],"gpt_icon":0},{"id":"2555318148","title":"Genedx Holdings Corp.跌3.73% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2555318148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555318148?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:34","pubTimestamp":1753968842,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时34分,Genedx Holdings Corp.股票出现异动,股价急速下挫3.73%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.72%。其相关个股中,Genedx Holdings Corp C/Wts 22/07/2026 、Exagen Inc.、奎斯特诊疗涨幅较大,Applied Dna Sciences, Inc.、Ispecimen Inc.、Bioaffinity Technologies, Inc.较为活跃,换手率分别为1.68%、1.57%、0.40%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Ispecimen Inc.、Guardant Health, Inc.,振幅分别为12.50%、10.04%、8.08%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121340294c66217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"1157496870","title":"异动解读 | GeneDx Holdings盘中大涨5.33%,Q2财报表现强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1157496870","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157496870?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:39","pubTimestamp":1753882774,"startTime":"0","endTime":"0","summary":"GeneDx Holdings今日盘中大涨5.33%,引起市场广泛关注。这一显著涨幅与公司刚刚发布的第二季度财报密切相关。根据财报显示,GeneDx Holdings 2025财年前六个月的表现令人瞩目。2025财年前六个月,GeneDx Holdings累计净利润为428.00万美元,而去年同期则为净亏损4941.20万美元。作为一家医疗保健技术公司,GeneDx Holdings的这一财务业绩表明公司在运营效率和市场拓展方面取得了显著进展。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"gpt_icon":1},{"id":"2555047389","title":"Genedx Holdings Corp.盘中异动 早盘股价大涨5.00%报96.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555047389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555047389?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:30","pubTimestamp":1753882224,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时30分,Genedx Holdings Corp.股票出现异动,股价快速拉升5.00%。截至发稿,该股报96.37美元/股,成交量3.458万股,换手率0.12%,振幅2.07%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为0.00%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213024a6c9d40f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2555009462","title":"美股财报 | GeneDx Holdings发布Q2财报 前半年累计净利润428.00万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555009462","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555009462?lang=zh_cn&edition=full","pubTime":"2025-07-30 12:00","pubTimestamp":1753848007,"startTime":"0","endTime":"0","summary":"genedx holdings发布Q2财报,2025财年前六月累计收入1.90亿美元,去年同期累计收入为1.33亿美元,同比增长42.78%。genedx holdings Corp.是一家于2020年7月10日在特拉华州注册成立的公司,Sema4是一家以患者为中心的健康情报公司,致力于通过数据驱动的洞察力推进医疗保健。Sema4通过将人工智能和机器学习应用于多维、纵向临床和基因组数据来构建人类健康的动态模型并定义最佳的个性化健康轨迹,从而改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730120552a46ac7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS"],"gpt_icon":0},{"id":"1118883267","title":"异动解读 | 业绩超预期,GeneDx Holdings夜盘大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118883267","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118883267?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:50","pubTimestamp":1753836654,"startTime":"0","endTime":"0","summary":"基因诊断公司GeneDx Holdings今日夜盘交易中股价大涨5.69%,延续了此前的强劲涨势。这一涨幅主要受到公司发布的2025年第二季度财报超出市场预期的推动。根据GeneDx Holdings发布的财报显示,公司第二季度调整后每股收益达到50美分,远超分析师平均预期的10美分,同时也大幅高于去年同期的亏损10美分。这份亮眼的财报无疑增强了投资者对GeneDx Holdings未来发展的信心。随着公司业绩的持续改善,GeneDx Holdings的股价有望继续保持上升势头。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"gpt_icon":1},{"id":"1104050750","title":"异动解读 | 业绩超预期,GeneDx Holdings盘前大涨29.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104050750","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104050750?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:43","pubTimestamp":1753796601,"startTime":"0","endTime":"0","summary":"7月29日周二,基因诊断公司GeneDx Holdings发布了截至6月30日的2025年第二季度财报,业绩大幅超出市场预期,导致该公司股价在盘前交易中飙升29.08%。财报显示,GeneDx Holdings第二季度调整后每股收益达到50美分,远超分析师平均预期的10美分,也大幅高于去年同期的亏损10美分。尽管GeneDx Holdings的股价在本季度下跌了8.0%,但今年迄今为止仍上涨了10.5%。这份亮眼的财报无疑将进一步增强投资者对GeneDx Holdings未来发展的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"gpt_icon":1},{"id":"2555301760","title":"GUIDANCE: (WGS) GeneDx Expects Full Year 2025 Revenue Range $400M - $415M, vs. FactSet Est of $369.4M","url":"https://stock-news.laohu8.com/highlight/detail?id=2555301760","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555301760?lang=zh_cn&edition=full","pubTime":"2025-07-29 18:52","pubTimestamp":1753786355,"startTime":"0","endTime":"0","summary":"GUIDANCE: (WGS) GeneDx Expects Full Year 2025 Revenue Range $400M - $415M, vs. FactSet Est of $369.4M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"指导:(WGS)GeneDx预计2025年全年收入范围为4亿至4.15亿美元,而FactSet预计为3.694亿美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WGS"],"gpt_icon":0},{"id":"2555603714","title":"GeneDx Hldgs Q2 2025 Adj. EPS $0.50 May Not Be Comparable To $0.10 Estimate, Sales $102.692M Beat $85.773M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2555603714","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555603714?lang=zh_cn&edition=full","pubTime":"2025-07-29 18:34","pubTimestamp":1753785244,"startTime":"0","endTime":"0","summary":"GeneDx Hldgs Q2 2025 Adj. EPS $0.50 May Not Be Comparable To $0.10 Estimate, Sales $102.692M Beat $85.773M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"GeneDx Hldgs 2025年第二季度调整后每股收益0.50美元可能无法与预期的0.10美元相比,销售额1.02692亿美元超出预期的8577.3万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/07/46682205/genedx-hldgs-q2-2025-adj-eps-0-50-may-not-be-comparable-to-0-10-estimate-sales-102-692m-beat-85-773","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"gpt_icon":0},{"id":"2555321703","title":"Genedx Holdings Corp.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555321703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555321703?lang=zh_cn&edition=full","pubTime":"2025-07-29 00:19","pubTimestamp":1753719559,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日00时19分,Genedx Holdings Corp.股票出现波动,股价快速拉升5.36%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为0.16%。其相关个股中,Genedx Holdings Corp.、燃石医学、Castle Biosciences, Inc.涨幅较大,Applied Dna Sciences, Inc.、Ispecimen Inc.、Genedx Holdings Corp.较为活跃,换手率分别为9.82%、3.65%、2.00%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.、Biodesix, Inc.,振幅分别为14.73%、13.71%、11.48%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729001919a4680db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2550969983","title":"Genedx Holdings Corp.盘中异动 急速跳水5.06%报82.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550969983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550969983?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:55","pubTimestamp":1752263702,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时55分,Genedx Holdings Corp.股票出现波动,股价快速下挫5.06%。截至发稿,该股报82.51美元/股,成交量72.5933万股,换手率2.54%,振幅5.09%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为0.04%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712035503a4456b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2550513678","title":"Genedx Holdings Corp.盘中异动 下午盘股价大跌5.07%报87.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550513678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550513678?lang=zh_cn&edition=full","pubTime":"2025-07-11 01:54","pubTimestamp":1752170076,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日01时54分,Genedx Holdings Corp.股票出现异动,股价快速跳水5.07%。截至发稿,该股报87.22美元/股,成交量43.7432万股,换手率1.53%,振幅4.91%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为2.28%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711015436953db952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2550065658","title":"Genedx Holdings Corp.盘中异动 早盘大幅拉升5.22%报89.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550065658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550065658?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:38","pubTimestamp":1752068323,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时38分,Genedx Holdings Corp.股票出现波动,股价快速拉升5.22%。截至发稿,该股报89.67美元/股,成交量4.4224万股,换手率0.15%,振幅3.07%。Genedx Holdings Corp.股票所在的生命科学行业中,整体涨幅为0.37%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213844953c35de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2549530457","title":"Genedx Holdings Corp.盘中异动 早盘快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530457?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895206,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分,Genedx Holdings Corp.股票出现波动,股价急速下挫5.03%。截至发稿,该股报87.00美元/股,成交量1.7714万股,换手率0.06%,振幅3.80%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.55%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康洞察,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213327a69b1a4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2546245883","title":"Genedx Holdings Corp.盘中异动 早盘股价大涨5.01%报95.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546245883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546245883?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:33","pubTimestamp":1750858400,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时33分,Genedx Holdings Corp.股票出现波动,股价急速上涨5.01%。截至发稿,该股报95.45美元/股,成交量6.7959万股,换手率0.24%,振幅3.58%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.29%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康见解,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213320a4bd70db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2545449343","title":"Genedx Holdings Corp.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545449343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545449343?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:35","pubTimestamp":1750696537,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时35分,Genedx Holdings Corp.股票出现波动,股价急速跳水5.03%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.73%。其相关个股中,Genedx Holdings Corp C/Wts 22/07/2026 、Mdxhealth Sa、Endra Life Sciences Inc.涨幅较大,Applied Dna Sciences, Inc.、Ispecimen Inc.、Prophase Labs, Inc.较为活跃,换手率分别为18.71%、2.41%、1.93%,振幅较大的相关个股有Prenetics Global Limited C/Wts 18/05/2027 、Applied Dna Sciences, Inc.、Insight Molecular Diagnostics Inc.,振幅分别为18.81%、17.77%、13.68%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康见解,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003538a4b98895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2544011231","title":"国家重大研发专项支持项目获重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2544011231","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544011231?lang=zh_cn&edition=full","pubTime":"2025-06-20 12:39","pubTimestamp":1750394340,"startTime":"0","endTime":"0","summary":"核心研究数据彰显技术颠覆性优势据了解,消化道癌症为高发癌症类型,占据全球癌症新发与死亡人数的23.9%和33.2%。而在中国,消化道癌症发病率及死亡率显著高于世界水平。由于消化道癌症存在早期症状隐匿的特点,多数患者确诊时已处于中晚期导致预后不佳。在中国,鹍远生物通过个商业化渠道建立了强大的布局,业务范围覆盖中国近百个城市的医院、体检中心及公共卫生项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-06-20/doc-infasynr2895020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","CE","WGS","BK4109","BK4196","TOO","BK4585"],"gpt_icon":0},{"id":"2542510511","title":"Genedx Holdings Corp.盘中异动 股价大跌5.04%报66.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542510511?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:59","pubTimestamp":1749736768,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时59分,Genedx Holdings Corp.股票出现异动,股价大幅下挫5.04%。截至发稿,该股报66.78美元/股,成交量8.2015万股,换手率0.29%,振幅4.71%。Genedx Holdings Corp.股票所在的生命科学行业中,整体跌幅为0.39%。Genedx Holdings Corp.公司简介:GeneDx Holdings Corp提供个性化且可操作的健康见解,为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612215928a7057404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":0.0456},{"period":"1month","weight":0.0774},{"period":"3month","weight":0.9344},{"period":"6month","weight":0.2415},{"period":"1year","weight":2.1883},{"period":"ytd","weight":0.6862}],"compareEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.1168},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.1624},{"period":"ytd","weight":0.1324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GeneDx Holdings Corp.是一家于2020年7月10日在特拉华州注册成立的公司,Sema4是一家以患者为中心的健康情报公司,致力于通过数据驱动的洞察力推进医疗保健。Sema4通过将人工智能和机器学习应用于多维、纵向临床和基因组数据来构建人类健康的动态模型并定义最佳的个性化健康轨迹,从而改变医疗保健。Centrellis是他们创新的健康智能平台,能够更全面地了解疾病和健康,并为最紧迫的医疗需求提供科学驱动的解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.176826},{"month":2,"riseRate":1,"avgChangeRate":0.457595},{"month":3,"riseRate":0.2,"avgChangeRate":-0.132973},{"month":4,"riseRate":0.2,"avgChangeRate":-0.003121},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013957},{"month":6,"riseRate":0.6,"avgChangeRate":0.029191},{"month":7,"riseRate":0.8,"avgChangeRate":0.138059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03863},{"month":10,"riseRate":0.75,"avgChangeRate":0.168214},{"month":11,"riseRate":0,"avgChangeRate":-0.217721},{"month":12,"riseRate":0.4,"avgChangeRate":-0.012987}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GeneDx Holdings(WGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GeneDx Holdings(WGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}